The next edition of Health at a Glance will be published on 8 November 2023
COVID‑19 contributed, directly and indirectly, to a 16% increase in the expected number of deaths in 2020 and the first half of 2021 across OECD countries. Life expectancy fell in 24 of 30 countries and the mental health impact of the pandemic has been huge. The pandemic has also led to a sharp increase in health spending across the OECD. Coupled with reductions in economic activity, the average health spending to GDP ratio jumped from 8.8% in 2019 to 9.7% in 2020.
READ MORE
The health impact of COVID-19 has been devastating, killing millions and causing long-lasting symptoms for many that survive. It has placed immense pressure on health care services that were often already overstretched before the pandemic.
©OECD
LEARN MORE...Life expectancy fell in most countries during the pandemic, mental distress has increased, and large health inequalities persist.
©OECD
LEARN MORE...Smoking, alcohol consumption, unhealthy nutrition, lack of physical activity and obesity are the root cause of many chronic conditions and increase the risk of people dying from COVID-19.
©OECD
LEARN MORE...Despite universal health coverage in most OECD countries, barriers to access remain, with COVID-19 disrupting health care for people with other needs.
©OECD
LEARN MORE...Quality of care is improving in terms of safety and effectiveness, and more attention is being placed on patient-reported outcomes and experiences.
©OECD
LEARN MORE...Pre-COVID-19, spending on health amounted to 8.8% of GDP on average across OECD countries. With the onset of COVID 19, sharp increases in health spending occurred in many countries, notably within Europe.
©OECD
LEARN MORE...The number of doctors and nurses have increased over the past decade in nearly all OECD countries, but shortages persist. These shortages have been thrown into sharp relief during the pandemic.
©OECD
LEARN MORE...Pharmaceuticals account for around one-sixth of health spending on average. Increased uptake of generics and biosimilars can increase value-for-money in health systems.
©OECD
LEARN MORE...Health systems should adapt to meet the needs of an ageing population, including a greater demand for labour-intensive long-term care and more integrated, person-centred care.
©OECD
LEARN MORE...
Available from November 09, 2021Also available in: French
Foreword | |||||||||||||||||||||||||||||
Reader’s guide | |||||||||||||||||||||||||||||
Executive summary | |||||||||||||||||||||||||||||
Indicator overview: Country dashboards and major trends | |||||||||||||||||||||||||||||
The health impact of COVID‑19 | |||||||||||||||||||||||||||||
Health status11 chapters available
|
|||||||||||||||||||||||||||||
Risk factors for health8 chapters available
|
|||||||||||||||||||||||||||||
Access: Affordability, availability and use of services12 chapters available
|
|||||||||||||||||||||||||||||
Quality and outcomes of care14 chapters available
|
|||||||||||||||||||||||||||||
Health expenditure9 chapters available
|
|||||||||||||||||||||||||||||
Health workforce11 chapters available
|
|||||||||||||||||||||||||||||
Ageing and long-term care11 chapters available
|